Fostemsavir Elbasvir / grazoprevir 27

Rukobia package insert

Clinical Bottom Line
Minimal data to guide interaction: risks likely to outweigh benefits benefit
Drug 1
Clinical Effects

Potentially increased exposure of grazoprevir and risk of ALT elevations

Management

Avoid combination; use alternative HCV regimen

Import ID
27